stars 1 stars 2 stars 3

Captix Biomedical Pty Ltd is a pioneering Australian company developing innovative, implantable, medical technologies to optimise the therapeutic outcomes of cell therapies. Captixbio’s IMITA™ device is a cell protection and delivery technology intended to transform the current cell therapy paradigm for the treatment of Type 1 diabetes. Our team is dedicated to transforming the lives of people living with Type 1 diabetes around the world.

Captixbio Questions

Captixbio is based in North Sydney, New South Wales.

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users